SCOPUS 정보 검색 플랫폼

Volumn 64, Issue 3, 2001, Pages 298-301

Vaccination with a CDR2 BV6S2/6S5 peptide in adjuvant induces peptide-specific t-cell responses in patients with multiple sclerosis

(7) Morgan, Elizabeth E a,b Nardo, Christopher J b Diveley, Jocelyn P b Kunin, Joel a,b Bartholomew, Richard M a,b Moss, Ronald B a,b Carlo, Dennis J a,b

a Orchestra Therapeutics Inc (United States)

b Sharp Rees Stealy Medical Group (United States)

Author keywords

MS clinical trials; Peptide induced immune responses; TCR peptide vaccines

Indexed keywords

AMINOLEUCYLGLYCYLGLUTAMINYLGLYCYLPROLYLGLUTAMYLPHENYLALANYLLEUCYLTHREONYLTY ROSYLPHENYLALANYLGLUTAMINYLASPARAGINYLGLUTAMYLALANYLGLUTAMINYLLEUCYLLYSYLSERINE CARBOXYLATE; FREUND ADJUVANT; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; VACCINE;

ADULT; ARTICLE; CELL ACTIVATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERANCE; FEMALE; HUMAN; IMMUNOGENICITY; LYMPHOCYTE PROLIFERATION; MALE; MULTICENTER STUDY; MULTIPLE SCLEROSIS; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SIDE EFFECT; SKIN TEST; T LYMPHOCYTE; VACCINATION;

ADULT; FEMALE; FREUND'S ADJUVANT; HUMANS; IMMUNITY, CELLULAR; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PEPTIDE FRAGMENTS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES;

EID: 0035340718 PISSN: 03604012 EISSN: None Source Type: Journal
DOI: 10.1002/jnr.1078 Document Type: Article

Times cited : (22)

References (11)

1
- 0028221789
- Immunity to TCR peptides in multiple sclerosis. I. Successful immunization of patients with synthetic V beta 5.2 and V beta 6.1 CDR2 peptides
- (1994) J Immunol , vol.152 , pp. 2510-2519
- Bourdette, D.N.¹ Whitham, R.H.² Chou, Y.K.³ Morrison, W.J.⁴ Atherton, J.⁵ Kenny, C.⁶ Liefeld, D.⁷ Hashim, G.A.⁸ Offner, H.⁹ Vandenbark, A.A.¹⁰

2
- 0032528428
- Immunity to T-cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarily-determining region determining peptides from disease-associated T-cell receptor BV genes
- (1998) J Immunol , vol.161 , pp. 1034-1044
- Bourdette, D.N.¹ Chou, Y.K.² Whitham, R.H.³ Buckner, J.⁴ Kwon, H.J.⁵ Nepom, G.T.⁶ Buenafe, A.⁷ Cooper, S.A.⁸ Allegretta, M.⁹ Hashim, G.A.¹⁰ Offner, H.¹¹ Vandenbark, A.A.¹²

3
- 0031007205
- Results of a phase I clinical trial of a T-cell receptor vaccine in patients with multiple sclerosis. II. Comparative analysis of TCR utilization in CSF T-cell populations before and after vaccination with a TCRVβ6 CDR2 peptide
- (1997) J Neuroimmunol , vol.76 , pp. 29-38
- Gold, D.P.¹ Smith, R.A.² Golding, A.B.³ Morgan, E.E.⁴ Dafashy, T.⁵ Nelson, J.⁶ Smith, L.⁷ Diveley, J.⁸ Laxer, J.A.⁹ Richieri, S.P.¹⁰ Carlo, D.J.¹¹ Brostoff, S.W.¹² Wilson, D.B.¹³

4
- 0024468234
- Vaccination against experimental allergic encephalomyelitis with T-cell receptor peptides
- published erratum appears in Science 247(4947): 1167, 1990
- (1989) Science , vol.246 , pp. 668-670
- Howell, M.D.¹ Winters, S.T.² Olee, T.³ Powell, H.C.⁴ Carlo, D.J.⁵ Brostoff, S.W.⁶

5
- 0026042680
- Preferential T-cell receptor beta-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis
- (1991) Proc Nad Acad Sci USA , vol.88 , pp. 9161-9165
- Kotzin, B.L.¹ Karuturi, S.² Chou, Y.K.³ Lafferty, J.⁴ Forrester, J.M.⁵ Better, M.⁶ Nedwin, G.E.⁷ Offner, H.⁸ Vandenbark, A.A.⁹

6
- 0028887507
- Immunodominant framework region 3 peptide from TCR V beta 8.2 chain controls murine experimental autoimmune encephalomyelitis
- (1995) J Immunol , vol.154 , pp. 1941-1950
- Kumar, V.¹ Tabibiazar, R.² Geysen, H.M.³ Sercarz, E.⁴

7
- 0021035886
- Kurtzke expanded disability status scale
- (1983) Neurology , vol.33 , pp. 1444-1452
- Kurtzke¹

8
- 17344364795
- T-cell receptor peptide vaccination in rheumatoid arthritis: A placebo controlled trial using a combination of Vβ3, Vβ14, and Vβ17 peptides
- (1998) Arthritis Rheum , vol.41 , pp. 1919-1929
- Moreland, L.W.¹ Morgan, E.E.² Adamson, T.C.³ Fronek, Z.⁴ Calabrese, L.H.⁵ Cash, J.M.⁶ Markenson, J.A.⁷ Matsumoto, A.K.⁸ Bathon, J.⁹ Matteson, E.L.¹⁰ Uramoto, K.M.¹¹ Weyand, C.M.¹² Koopman, W.J.¹³ Heck, L.W.¹⁴ Strand, V.¹⁵ Diveley, J.P.¹⁶ Carlo, D.J.¹⁷ Nardo, C.J.¹⁸ Richieri, S.P.¹⁹ Brostoff, S.W.²⁰ more..

9
- 0018117410
- The rate of hydrolysis of methyl phosphotriesters in DNA under conditions used in alkaline sucrose gradients
- (1978) Biochim Biophys Acta , vol.521 , pp. 155-159
- Shooter, K.V.¹ Merrifield, R.K.²

10
- 16044361810
- Treatment of multiple sclerosis with T-cell receptor peptides: Results of a double-blind pilot trial
- (1996) Nat Med , vol.2 , pp. 1109-1115
- Vandenbark, A.A.¹ Chou, Y.K.² Whitham, R.³ Mass, M.⁴ Buenefe, A.⁵ Liefield, D.⁶ Kavanagh, D.⁷ Cooper, S.⁸ Hashim, G.A.⁹ Offner, H.¹⁰ Bourdette, D.N.¹¹

11
- 0031007204
- Results of a phase I clinical trial of a T-cell receptor peptide vaccine in patients with multiple sclerosis. I. Analysis of T-cell receptor utilization in CSF cell populations
- (1996) J Neuroimmunol , vol.76 , pp. 15-28
- Wilson, D.B.¹ Golding, A.B.² Smith, R.A.³ Dafashy, T.⁴ Nelson, J.⁵ Smith, L.⁶ Carlo, D.J.⁷ Brostoff, S.W.⁸ Gold, D.P.⁹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.